These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 30527358)
41. Reciprocal control of lncRNA-BCAT1 and β-catenin pathway reveals lncRNA-BCAT1 long non-coding RNA acts as a tumor suppressor in colorectal cancer. Xie F; Xiang X; Huang Q; Ran P; Yuan Y; Li Q; Qi G; Guo X; Xiao C; Zheng S Oncotarget; 2017 Apr; 8(14):23628-23637. PubMed ID: 28416735 [TBL] [Abstract][Full Text] [Related]
42. LncRNA SNHG12 promotes proliferation and migration of hepatic progenitor cells via the Wnt/β-catenin pathway. Liu P; Wang J; Du W; Chen L Adv Clin Exp Med; 2023 Sep; 32(9):1017-1027. PubMed ID: 36994689 [TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2. Xiu DH; Liu GF; Yu SN; Li LY; Zhao GQ; Liu L; Li XF J Exp Clin Cancer Res; 2019 Feb; 38(1):94. PubMed ID: 30791958 [TBL] [Abstract][Full Text] [Related]
44. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517 [TBL] [Abstract][Full Text] [Related]
45. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway. Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312 [TBL] [Abstract][Full Text] [Related]
46. HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β-catenin signaling. Chen Z; Zhou L; Wang L; Kazobinka G; Zhang X; Han X; Li B; Hou T Mol Carcinog; 2018 Jan; 57(1):12-21. PubMed ID: 28796367 [TBL] [Abstract][Full Text] [Related]
47. lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression. She K; Huang J; Zhou H; Huang T; Chen G; He J Oncol Rep; 2016 Nov; 36(5):2673-2680. PubMed ID: 27666964 [TBL] [Abstract][Full Text] [Related]
48. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Tuo Z; Zhang J; Xue W Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110 [TBL] [Abstract][Full Text] [Related]
49. Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/β-catenin signaling in gastric cancer cells. Xu W; He L; Li Y; Tan Y; Zhang F; Xu H Biosci Biotechnol Biochem; 2018 Mar; 82(3):456-465. PubMed ID: 29424266 [TBL] [Abstract][Full Text] [Related]
50. A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/β‑catenin signaling pathway. Huang Z; Gao H; Qing L; Wang B; He C; Luo N; Lu C; Fan S; Gu P; Zhao H PeerJ; 2022; 10():e13220. PubMed ID: 35433119 [TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma. Huang JL; Liao Y; Qiu MX; Li J; An Y Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366 [TBL] [Abstract][Full Text] [Related]
52. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression. Zhang Y; Tan Y; Wang H; Xu M; Xu L Med Sci Monit; 2019 Oct; 25():7652-7659. PubMed ID: 31604907 [TBL] [Abstract][Full Text] [Related]
53. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway. Shi X; Cui Z; Liu X; Wu S; Wu Y; Fang F; Zhao H Biochem Biophys Res Commun; 2019 Mar; 510(4):594-600. PubMed ID: 30739786 [TBL] [Abstract][Full Text] [Related]
54. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway. Wang Y; Zhou J; Xu YJ; Hu HB J Cell Physiol; 2018 Apr; 233(4):3397-3406. PubMed ID: 28926089 [TBL] [Abstract][Full Text] [Related]
55. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway. Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286 [TBL] [Abstract][Full Text] [Related]
56. LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway. Gong X; Liao X; Huang M Pathol Res Pract; 2019 Mar; 215(3):564-570. PubMed ID: 30661904 [TBL] [Abstract][Full Text] [Related]
57. LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Shan Y; Ma J; Pan Y; Hu J; Liu B; Jia L Cell Death Dis; 2018 Jun; 9(7):722. PubMed ID: 29915311 [TBL] [Abstract][Full Text] [Related]
58. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma. Deng Y; Zhao F; Zhang Z; Sun F; Wang M Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838 [TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway. Wang CH; Li YH; Tian HL; Bao XX; Wang ZM Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244 [TBL] [Abstract][Full Text] [Related]
60. Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway. Geng W; Guo X; Zhang L; Ma Y; Wang L; Liu Z; Ji H; Xiong Y Biomed Pharmacother; 2018 Nov; 107():484-494. PubMed ID: 30107344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]